Loading clinical trials...
Loading clinical trials...
The study hypothesis is that changes in serially obtained nerve conduction study data obtained every 3-4 weeks in cancer patients receiving chemotherapy can be used to predict the development of a cli...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
NeuroMetrix, Inc.
NCT07670221 · Chemotherapy-Related Taste Alteration
NCT07226986 · PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
NCT06389721 · Chemotherapy-induced Peripheral Neuropathy
NCT05941741 · Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, and more
NCT05838638 · Neoplasms, Chemotherapy-induced Nausea and Vomiting
Santa Clara Valley Health and Hospital System
Santa Clara, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions